Skip to content
Home / News |

N4 Pharma Shares Surged 18.4% Today, Here’s Why

Shares of N4 Pharma PLC (LON: N4P) today surged 18.4% despite the lack of significant releases from the company in a rally driven by investor optimism about the company’s future.

The last time the specialist pharmaceutical company made an announcement was followed by a massive decline as it announced that it was planning to start a new COVID-19 study after the first one failed to yield positive results.

It seems like investors are betting on positive results from the company any time soon and are buying the company’s stock in anticipation of the same.

X testing X
WELCOME BONUS - Free Share Bundle When You Invest £50! Get up to £500 cashback for investing with IG.
Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.
5.0
Open Account Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

I believe that investor confidence in the company is warranted given the initial positive results of its COVID-19 vaccine proof-of-concept, hence, it wouldn’t be surprising to see the company make another major breakthrough in this direction.

N4 Pharma share price

Tradingview chart of N4 Pharma share price 21102020

N4 Pharma shares today surged 18.4% to trade at 9.0p having risen from Tuesday’s closing price of 7.6p.

People who read this also read:

Simon Mugo
Contributor

Simon ist Autor und Analyst für den Bereich Finanzwesen und blickt auf über sechs Jahre professionelle Erfahrung als Trader zurück. Er absolvierte einen Bachelor in Mathematik und Informatik und hat eine Leidenschaft für die Finanzmärkte. Simon handelt FX, Rohstoffe und Aktien. Er konzentriert sich auf Price Action Trading.